Myers Scott Dunseth
SEC CIK 1356256 · EDGAR
BoughtSold
Most active insiders at ZNTL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | WALTERS GROUP | 10% | $15.17M | — |
| 2 | GOEL DAVID E. | 10% | — | $9.97M |
| 3 | WALTERS WILLIAM THURMAN | 10% | $7.75M | — |
| 4 | Vultaggio Vincent | PAO, PFO | — | $105.4K |
| 5 | EASTLAND JULIA MARIE | CEO, Pres, Dir | — | $21.2K |
| 6 | Bruns Ingmar | Chief Medical Off | — | $7,998 |
| 7 | Campbell Shannon | Dir | — | — |
| 8 | Kariuki Enoch | Dir | — | — |
| 9 | Skvarka Jan | Dir | — | — |
| 10 | Johnson David Michael | Dir | — | — |
| 12 | Myers Scott Dunseth | Dir | — | — |
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-18 16:06 | 2026-06-16 | ZNTL | Zentalis Pharmaceuticals, Inc. | Myers Scott Dunseth | Dir | A - Grant | $0.00 | +57.1K | 395.9K | +17% | $0 | |
| 2025-06-18 | 2025-06-17 | ZNTL | Zentalis Pharmaceuticals, Inc. | Myers Scott Dunseth | Dir | A - Grant | $0.00 | +57.6K | 338.8K | +20% | $0 | |
| 2025-04-30 | 2025-04-30 | ZNTL | Zentalis Pharmaceuticals, Inc. | Myers Scott Dunseth | Dir | P - Purchase | $1.40 | +21.0K | 281.2K | +8% | +$29.4K | |
| 2024-11-13 | 2024-11-13 | ZNTL | Zentalis Pharmaceuticals, Inc. | Myers Scott Dunseth | Dir | A - Grant | $0.00 | +260.2K | 260.2K | New | $0 | |
| 2023-04-12 | 2023-04-12 | VRDN | Viridian Therapeutics, Inc.\DE | Myers Scott Dunseth | CEO, Dir | P - Purchase | $25.37 | +4,000 | 259.5K | +2% | +$101.5K | |
| 2023-03-13 | 2023-03-13 | VRDN | Viridian Therapeutics, Inc.\DE | Myers Scott Dunseth | CEO, Dir | P - Purchase | $29.15 | +5,500 | 255.5K | +2% | +$160.3K | |
| D | 2023-02-07 | 2023-02-06 | VRDN | Viridian Therapeutics, Inc.\DE | Myers Scott Dunseth | CEO, Dir | A - Grant | $0.00 | +250.0K | 250.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations